Provexis Plc engages in the development and commercialization of Fruitflow, an anti-thrombotic technology. The Fruitflow is a scientifically-proven tomato extract which inhibits platelet aggregation. The company was founded in 1999 and is headquartered in Reading, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company